Navigation Links
Drug Company-Funded Asthma Drug Studies More Positive
Date:10/23/2007

Expert review finds fewer adverse effects reported

TUESDAY, Oct. 23 (HealthDay News) -- Drug company-funded studies of asthma drugs called inhaled corticosteroids are less likely to find adverse effects than studies that were paid for by other sources, Spanish researchers say.

A team from Children's Hospital La Fe in Valencia analyzed 504 studies of the drugs conducted between 1993 and 2002.

Potentially harmful decreases in the stress hormone cortisol, decreases in bone mineral density, and growth suppression are among the adverse effects that have been associated with inhaled corticosteroids, the researchers note.

Of the 504 studies, 275 were funded by drug companies and 229 were funded by other sources, such as government agencies and non-profit organizations.

The researchers found that 34.5 percent of drug company-funded studies and 65.1 percent of studies funded by other sources identified significant differences in adverse events between patients who took inhaled corticosteroids and those in control groups who didn't take the drugs.

The researchers said the difference was no longer statistically significant when they factored in components of study design, such as dosage amounts or a focus limited to specific adverse effects. This suggests that the association between funding source and more positive findings may be the result of variations in how the studies were designed, said the researchers.

They noted that it's difficult to determine if drug company-funded studies are too positive or whether studies funded by other sources are too cautious.

Still, "having information on source of funding will help readers of these studies have a better informed and balanced judgment on the authors' interpretations," they concluded. "Disclosure of conflicts of interest should be strengthened for a more balanced opinion of the safety of drugs."

The study appears in the Oct. 22 issue of the journal Archives of Internal Medicine.

More information

The American Lung Association has more about asthma medications.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Oct. 22, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Drug for Bronchial Asthma
2. Asthma may actually be prevented by Dust and Dirt
3. Inhaled Steroids Safe & Effective for Children with Asthma
4. What happens when Asthmatics consume Aspirin?
5. Fireworks can spell death for asthmatic children
6. New vaccine helps allergy and asthma patients
7. New vaccine helps allergy and asthma patients
8. Nearly all asthma deaths preventable
9. Asthma! A new warning for heart disease
10. Soluble IL-4 Receptor - A new boon for asthmatics
11. Cats to protect children from asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis ... Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved ... states. Ingredients in HeartBoost, an over the counter heart healthy drink, can reduce ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... provides insight into the challenges employers face in trying to balance both short-term ... employee benefits programs? Adding to the growing complexity, companies are finding that ...
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general dentist in ... pediatric patients, with or without a referral. Dr. Cotey knows that interceptive orthodontics ... and experience. When patients receive early treatment, they may achieve straight teeth with less ...
(Date:3/29/2017)... ... March 29, 2017 , ... How big ... outpatient facilities, and who are the most active developers? , In the ... Healthcare Real Estate Insights (HREI) found that outpatient medical real estate development projects ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... March 30, 2017 Revenue Prospects by Product ... and COPD) and Geography Respiratory Inhalers - our new ... the Respiratory Inhalers market heading? If you are involved in this ... report shows you the potential revenues streams to 2027, assessing data, ... ...
(Date:3/29/2017)... , Mar. 29, 2017 Research ... Neuromonitoring (IONM) Market Size & Forecast By Type (Insource IONM, ... 2025" report to their offering. ... The global Intraoperative Neuromonitoring ... 2025. The intraoperative neuromonitoring market is anticipated to witness significant ...
(Date:3/29/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global energy-based aesthetic devices market to grow at ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
Breaking Medicine Technology: